204 related articles for article (PubMed ID: 28122346)
1. SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.
Mukherjee N; Cardenas E; Bedolla R; Ghosh R
Oncotarget; 2017 Feb; 8(9):15114-15125. PubMed ID: 28122346
[TBL] [Abstract][Full Text] [Related]
2. MiR-411 inhibits gastric cancer proliferation and migration through targeting SETD6.
Bai TL; Liu YB; Li BH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3344-3350. PubMed ID: 31081088
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.
Zheng J; Kong C; Yang X; Cui X; Lin X; Zhang Z
BMC Cancer; 2017 Jun; 17(1):432. PubMed ID: 28629334
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
5. The regulatory effects of polyporus polysaccharide on the nuclear factor kappa B signal pathway of bladder cancer cells stimulated by Bacillus Calmette-Guerin.
Wei JA; Zeng X; Han L; Huang Y
Chin J Integr Med; 2011 Jul; 17(7):531-6. PubMed ID: 21725879
[TBL] [Abstract][Full Text] [Related]
6. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
7. Investigating the functional role of SETD6 in lung adenocarcinoma.
Xu J; Zhou H; Luo Z; Chen J; Liu M
BMC Cancer; 2023 Jan; 23(1):18. PubMed ID: 36604642
[TBL] [Abstract][Full Text] [Related]
8. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling.
Levy D; Kuo AJ; Chang Y; Schaefer U; Kitson C; Cheung P; Espejo A; Zee BM; Liu CL; Tangsombatvisit S; Tennen RI; Kuo AY; Tanjing S; Cheung R; Chua KF; Utz PJ; Shi X; Prinjha RK; Lee K; Garcia BA; Bedford MT; Tarakhovsky A; Cheng X; Gozani O
Nat Immunol; 2011 Jan; 12(1):29-36. PubMed ID: 21131967
[TBL] [Abstract][Full Text] [Related]
9. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
10. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
Jiang Y; Han Y; Sun C; Han C; Han N; Zhi W; Qiao Q
Tumour Biol; 2016 Jun; 37(6):8131-8. PubMed ID: 26715272
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guérin through nuclear factor-kappaB and Ap-1 via an immediate early pathway.
Chen FH; Crist SA; Zhang GJ; Iwamoto Y; See WA
J Urol; 2002 Aug; 168(2):786-97. PubMed ID: 12131369
[TBL] [Abstract][Full Text] [Related]
12. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling.
Chang Y; Levy D; Horton JR; Peng J; Zhang X; Gozani O; Cheng X
Nucleic Acids Res; 2011 Aug; 39(15):6380-9. PubMed ID: 21515635
[TBL] [Abstract][Full Text] [Related]
14. Bladder neoplasms and NF-κB: an unfathomed association.
Walter CEJ; Durairajan S; Periyandavan K; C GPD; G DJD; A HRV; Johnson T; Zayed H
Expert Rev Mol Diagn; 2020 May; 20(5):497-508. PubMed ID: 32228251
[No Abstract] [Full Text] [Related]
15. Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.
Li G; Wang M; Ren L; Li H; Liu Q; Ouyang Y; He L; Li F
Biomed Pharmacother; 2019 Sep; 117():109112. PubMed ID: 31212130
[TBL] [Abstract][Full Text] [Related]
16. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W
J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843
[TBL] [Abstract][Full Text] [Related]
17. To be an ally or an adversary in bladder cancer: the NF-κB story has not unfolded.
Mukherjee N; Houston TJ; Cardenas E; Ghosh R
Carcinogenesis; 2015 Mar; 36(3):299-306. PubMed ID: 25543121
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
[TBL] [Abstract][Full Text] [Related]
19. Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA.
Huang W; Liu H; Lv T
Histol Histopathol; 2021 Feb; 36(2):229-237. PubMed ID: 33710605
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.
Ito Y; Kikuchi E; Tanaka N; Kosaka T; Suzuki E; Mizuno R; Shinojima T; Miyajima A; Umezawa K; Oya M
BMC Cancer; 2015 Apr; 15():324. PubMed ID: 25926105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
